Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemia

J Hepatol. 2006 Feb;44(2):432-3; author reply 433. doi: 10.1016/j.jhep.2005.10.020. Epub 2005 Nov 21.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Cryoglobulinemia / complications*
  • Cryoglobulinemia / drug therapy
  • DNA, Viral / drug effects
  • DNA, Viral / genetics
  • Drug Therapy, Combination
  • Hepacivirus* / drug effects
  • Hepacivirus* / genetics
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Kidney Diseases / drug therapy*
  • Kidney Diseases / etiology
  • Kidney Diseases / virology
  • Polyethylene Glycols
  • Recombinant Proteins
  • Ribavirin / therapeutic use*
  • Treatment Outcome

Substances

  • Antiviral Agents
  • DNA, Viral
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2b